Report: FDA approved the most drugs in 4 years in 2009

01/5/2010 | Wall Street Journal, The

The FDA approved 26 new treatments in 2009, the most in four years but only one more than in 2008, according to a Washington Analysis report. Blood thinner Effient, by Eli Lilly and Co. and Daiichi Sankyo, and Sanofi-Aventis' heart drug Multaq were among the approvals, while Novo Nordisk's liraglutide for diabetes and Amgen's osteoporosis drug denosumab failed to secure approval.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA